The emerging patent landscape of CRISPR–Cas gene editing technology

Knut J Egelie,Gregory D Graff,Sabina P Strand,Berit Johansen
DOI: https://doi.org/10.1038/nbt.3692
IF: 46.9
2016-10-01
Nature Biotechnology
Abstract:Early views on the control of the CRISPR–Cas disruptive enabling technology and access for follow-on commercial applications.
biotechnology & applied microbiology
What problem does this paper attempt to address?